IMCD Stock - Analyst consensus and strategy in focus

IMCD stock is trading without fresh price-moving news, but the Dutch specialty chemicals distributor remains on analysts’ radar with a solid consensus view and a clear asset-light growth strategy. A look at ratings, estimates and the business model.

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 20:31 CET. Details in the imprint.

IMCD (NL0010801007) draws attention today without a fresh market-moving headline. Instead, the stock remains framed by a stable analyst consensus and the company’s asset-light distribution strategy in specialty chemicals, as reflected in recent broker data and public filings.

What recent updates show

IMCD has not published a new ad-hoc or major press release in the past day, and there is no fresh Reuters or Bloomberg headline altering the investment narrative. The latest corporate information remains centered on previously reported strategic progress and integration of past acquisitions.

The company’s Investor Relations materials emphasize its role as a global distributor of specialty chemicals and ingredients, highlighting a multi-year track record of growth in revenue and adjusted EBITA. Management continues to stress capital discipline and bolt-on acquisitions as tools to expand its technical sales network and formulation labs.

Analyst consensus on IMCD

Analyst coverage of IMCD remains robust, with several European banks and brokers publishing regular estimates on revenue growth, margins and earnings per share. Consensus models typically factor in mid-single-digit to high-single-digit organic growth plus contributions from acquisitions over the medium term.

Price targets collected by data providers cluster around a premium to the current share price, reflecting the market’s recognition of IMCD’s asset-light model and strong positions in niche end-markets. Rating distributions are tilted toward positive or neutral stances, with only a minority of outright negative recommendations reported by aggregators.

How IMCD makes its money

IMCD generates revenue by distributing and formulating specialty chemicals and food, pharma and industrial ingredients for a broad base of suppliers and customers. The group operates an asset-light model, focusing on technical expertise, formulation support and supply-chain services rather than large-scale manufacturing assets.

Where the stock trades today

The shares of IMCD (NL0010801007) trade on Euronext Amsterdam; the latest available quote shows the stock changing hands at around EUR 130 per share in recent trading, based on delayed exchange data as of 06/17/2026, 20:31 CET.

Key facts on IMCD stock

• Company: IMCD N.V.
• ISIN: NL0010801007
• WKN: A1W3AP
• Ticker: IMCD
• Venue: Euronext Amsterdam
• Price (as of 06/17/2026, 20:31 CET): 130.00 EUR
• Market cap: 6,800,000,000 EUR (as of 06/17/2026)
• Sector / Industry: Materials / Specialty Chemicals Distribution
• Index membership: Euronext Amsterdam indices
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.